The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
- 28 February 2011
- journal article
- research article
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 191 (2), 122-127
- https://doi.org/10.1016/j.pscychresns.2010.10.009
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trialInternational Journal of Neuropsychopharmacology, 2010
- The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood DisordersThe Neuroscientist, 2009
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive DisorderJournal of Clinical Psychopharmacology, 2008
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008
- Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS StudyAmerican Journal of Psychiatry, 2005
- Increased Cortical GABA Concentrations in Depressed Patients Receiving ECTAmerican Journal of Psychiatry, 2003
- Increased Occipital Cortex GABA Concentrations in Depressed Patients After Therapy With Selective Serotonin Reuptake InhibitorsAmerican Journal of Psychiatry, 2002
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)Journal of Traumatic Stress, 1998
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993